|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||10.21 - 10.82|
|52 Week Range||5.30 - 86.40|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||49.68|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
EDMONTON, AB , July 6, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (ACB) (ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Miguel Martin , President of Aurora USA and head of Reliva, LLC ("Reliva"), has been appointed Chief Commercial Officer of Aurora, effective immediately. Mr. Martin will replace Darren Karasiuk who has held this position at Aurora since February 2019 .
EDMONTON, AB, June 29, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE:ACB - News) (TSX:ACB - News), the Canadian company defining the future of cannabinoids worldwide, today announced that Co-Founder Terry Booth has retired from his role as Director of the Company, effective June 26, 2020. Mr. Booth was the Chief Executive Officer of Aurora from December 2014 through February 2020 and served on Aurora's Board of Directors since December 2014. "On behalf of our Board of Directors and management team, I would like to thank Terry for his leadership over the years and for his tenure as a director," said Michael Singer, Executive Chairman and Interim CEO of Aurora.
Alcanna Inc. (the “Company”) (CLIQ.TO) and Aurora Cannabis Inc. (“Aurora”) (NYSE/TSX: ACB) jointly announce the successful closing of the Company's secondary offering of 9,200,000 common shares of the Company (the “Offered Shares”) held by an indirect, wholly-owned subsidiary of Aurora (the “Selling Shareholder”) at a price of $3.00 per Offered Share by way of short form prospectus for total gross proceeds to the Selling Shareholder of approximately $27.6 million (the “Offering”). No common shares of the Company (the “Common Shares”) were sold from treasury pursuant to the Offering.